Literature DB >> 9274853

Prevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8.

T Matsumoto1, K Ikeda, N Mukaida, A Harada, Y Matsumoto, J Yamashita, K Matsushima.   

Abstract

Reperfusion after a transient ischemia is a frequently encountered clinical condition that often causes greater tissue damage than persistent ischemia itself. Reperfusion to rabbit brain, after a transient focal ischemia, induced neutrophil infiltration and aggregation--neither of which were observed in rabbit brain rendered ischemic alone for the same time interval--thereby leading to severe brain edema and infarct. Brain tissue levels of interleukin-8 (IL-8), a potent neutrophil chemotactic cytokine (chemokine), increased significantly at 6 hours after reperfusion, but without a noticeable elevation of plasma IL-8 levels. Moreover, we detected IL-8 protein immunohistologically in the vascular wall and, to a lesser degree, in infiltrated neutrophils, suggesting a local production of IL-8 in reperfused brain tissues. Furthermore, a neutralizing anti-IL-8 antibody significantly reduced brain edema and infarct size in comparison to rabbits receiving a control antibody. These results implicate locally produced IL-8 as a pivotal mediator of cerebral reperfusion and suggest that IL-8 is a novel target for the intervention of this injury.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9274853

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  27 in total

1.  An in vivo approach showing the chemotactic activity of leukotriene B(4) in acute renal ischemic-reperfusion injury.

Authors:  E Noiri; T Yokomizo; A Nakao; T Izumi; T Fujita; S Kimura; T Shimizu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  Treatment with a monocolonal antibody to IL-8 attenuates the pleocytosis in experimental pneumococcal meningitis in rabbits when given intravenously, but not intracisternally.

Authors:  C Ostergaard; R V Yieng-Kow; C G Larsen; N Mukaida; K Matsushima; T Benfield; N Frimodt-Møller; F Espersen; A Kharazmi; J D Lundgren
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 3.  [Chemokine--possible new options for the treatment of multiple sclerosis].

Authors:  C Trebst; R M Ransohoff; A Windhagen; M Stangel
Journal:  Nervenarzt       Date:  2003-10       Impact factor: 1.214

Review 4.  Chemokines and glial cells: a complex network in the central nervous system.

Authors:  Elena Ambrosini; Francesca Aloisi
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

Review 5.  Role of chemokines in ischemic neuronal stress.

Authors:  Masabumi Minami; Masamichi Satoh
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

6.  Intracerebral Hemorrhage Induces Inflammatory Gene Expression in Peripheral Blood: Global Transcriptional Profiling in Intracerebral Hemorrhage Patients.

Authors:  Kyle B Walsh; Xiang Zhang; Xiaoting Zhu; Eric Wohleb; Daniel Woo; Long Lu; Opeolu Adeoye
Journal:  DNA Cell Biol       Date:  2019-05-22       Impact factor: 3.311

7.  Slit modulates cerebrovascular inflammation and mediates neuroprotection against global cerebral ischemia.

Authors:  Tamer Altay; Bethann McLaughlin; Jane Y Wu; T S Park; Jeffrey M Gidday
Journal:  Exp Neurol       Date:  2007-07-26       Impact factor: 5.330

Review 8.  Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks.

Authors:  Bridgette D Semple; Thomas Kossmann; Maria Cristina Morganti-Kossmann
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-11       Impact factor: 6.200

9.  Transcriptome analysis of the hippocampal CA1 pyramidal cell region after kainic acid-induced status epilepticus in juvenile rats.

Authors:  Hanna B Laurén; Francisco R Lopez-Picon; Annika M Brandt; Clarissa J Rios-Rojas; Irma E Holopainen
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

10.  Brain endothelial cell-cell junctions: how to "open" the blood brain barrier.

Authors:  Svetlana M Stamatovic; Richard F Keep; Anuska V Andjelkovic
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.